Fundamentals

Valuation

Metric	Q2	Q4	Δ in %
EV/EBITDA	-50.69	16.49	33.45
Graham Fair Price	20.18	1.69	1.40
PEG	0.00	0.00	0.00
Price/Book	-40.02	0.16	0.27
Price/Cash Flow	98.31	-1.09	-64.79
Prices/Earnings	59.80	-2.49	-6.20
Price/Sales	-35.43	0.30	0.47
Price/FCF	98.31	-1.09	-64.79
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q2	Q4	Δ in %
Gross Profit Margin	-8.90	0.08	0.09
Operating Margin	499.61	-0.02	< 0.005
ROA	-58.02	< 0.005	< 0.005
ROE	-0.01	-0.02	-49.20
ROIC	< 0.005	< 0.005	421.55
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q2	Q4	Δ in %
Debt QOQ	0.00	0.00	0.00
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.00	0.00	0.00
EPS QOQ	0.00	0.00	0.00
FCF QOQ	0.00	0.00	0.00
Revenue QOQ	0.00	0.00	0.00
Naive Interpretation	member

03 - Financial Growth · Not Interpreted

Fundamentals

Leverage & Liquidity

Metric	Q2	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	3.11	3.27	5.13
Days Sales Outstanding (DSO)	483.23	498.01	3.06
Inventory Turnover	28.94	27.53	-4.88
Debt/Capitalization	0.22	0.27	20.82
Quick Ratio	1.21	1.23	2.25
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q2	Q4	Δ in %
Book Value	2.82	2.78	-1.61
Cash	0.37	0.18	-51.78
Capex	-0.06	-0.16	-185.43
Free Cash Flow	-0.01	-0.41	-3395.92
Revenue	1.65	1.50	-8.61
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q2	Q4	Δ in %
Current Ratio	1.32	1.34	1.27
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	15.08	10.86	-27.97
Naive Interpretation	Member

06 - Financial Health · Weak

Rating